Cd28-b7 interaction

Definition

The CD28-B7 interaction is a crucial co-stimulatory signal that occurs between T cells and antigen-presenting cells (APCs), specifically involving the CD28 receptor on T cells and the B7 molecules (CD80/CD86) on APCs. This interaction is essential for T cell activation, survival, and proliferation, significantly influencing the immune response and contributing to the mechanisms of tolerance to prevent autoimmunity.

5 Must Know Facts For Your Next Test

1. The CD28 receptor is constitutively expressed on T cells and binds to B7 molecules, which are expressed on activated APCs, providing a necessary second signal for full T cell activation.
2. The interaction enhances cytokine production by T cells and promotes their survival, as it helps prevent apoptosis during immune responses.
3. In addition to CD28, there are other co-stimulatory receptors like CTLA-4 that can bind to B7 molecules but inhibit T cell activation, highlighting the balance between activation and regulation.
4. Failure of CD28-B7 interactions can lead to inadequate T cell responses, potentially resulting in immunodeficiency or failure to eliminate cancer cells.
5. The CD28-B7 pathway plays a significant role in maintaining peripheral tolerance by influencing the fate of T cells that recognize self-antigens, preventing autoimmunity.

Review Questions

• How does the CD28-B7 interaction influence T cell activation and what are its implications for immune responses?
  • The CD28-B7 interaction is essential for T cell activation as it provides a necessary co-stimulatory signal alongside antigen recognition. This interaction not only promotes T cell proliferation but also enhances cytokine production and survival. Without this second signal, T cells may become anergic or undergo apoptosis, leading to weakened immune responses against infections or tumors.
• Discuss the role of CD28-B7 interactions in establishing and maintaining peripheral tolerance within the immune system.
  • CD28-B7 interactions play a crucial role in establishing peripheral tolerance by modulating the response of T cells that encounter self-antigens. When these interactions occur under specific conditions, they can promote anergy or regulatory T cell differentiation rather than full activation. This mechanism is vital for preventing autoimmunity by ensuring that potentially harmful self-reactive T cells do not mount an aggressive immune response against the body's own tissues.
• Evaluate the potential therapeutic implications of targeting CD28-B7 interactions in treating autoimmune diseases or cancer.
  • Targeting CD28-B7 interactions presents both opportunities and challenges in therapeutic contexts. For autoimmune diseases, inhibiting this pathway could enhance tolerance and reduce unwanted immune activation against self-tissues. Conversely, in cancer treatment, stimulating CD28 signaling could boost anti-tumor responses by enhancing T cell activation against cancer cells. Thus, understanding this balance is crucial for developing effective therapies that harness or modulate these interactions according to clinical needs.

Related terms

T Cell Activation: The process by which T cells undergo a series of changes that lead to their proliferation and differentiation in response to antigens.

Antigen-Presenting Cells (APCs):

Cells that process and present antigens to T cells, playing a vital role in initiating the adaptive immune response.

Tolerance: The state of unresponsiveness of the immune system to specific antigens, which can be central (developed in the thymus) or peripheral (developed outside of the thymus).